FDA Approves Presbyopia Contact Lenses with Extended Depth of Focus
Here’s a breakdown of the key data from the provided text:
Key Players & Organizations:
* Salution Health: Described as “the world’s first fully integrated human + AI-powered health accelerator.”
* Salution Nexus: Salution Health’s “global regulatory and clinical strategy engine.”
* Malvina Eydelman, MD: Cofounder of Salution Health, and a consultant for Bruno Vision Care.
* Deseyne: A new brand of hydrating contact lenses.
* Cataltheia Group: Founded by Catalfamo.
* Bruno Vision Care: Eydelman is a consultant for this company.
* Healio: The publisher of this news article.
Product & Approval:
* Deseyne contact lenses featuring fusiontechnology were approved by the FDA in April.
* FusionTechnology: A patented system that uses body temperature,blinking,and eyelid pressure to release a tear-like “natural copolymer” from the lens to the eye.
Salution’s Role:
* Salution Nexus provided regulatory and scientific expertise that was crucial to the FDA submission for Deseyne lenses.
* Their work helped create a strong evidence base and regulatory approach, contributing to the product’s accomplished U.S. market entry.
Disclosures:
* Catalfamo is the cofounder and CEO of Cataltheia Group.
* Eydelman is the cofounder of Salution Health and a consultant for Bruno Vision Care.
* Healio could not confirm Bullimore’s financial disclosures.
Additional Feature:
* The article includes a promotional section for Healio AI, an AI-powered knowledge base that draws from sources like PubMed, clinical guidelines, and Healio’s news coverage.